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Abstract
C23H16N2OS, orthorhombic, Pna21 (no. 33), a= 19.4988(9) Å,
b= 19.5060(9) Å, c= 9.2893(4) Å, V = 3533.1(3) Å3, Z= 8,
Rgt(F)=0.0501, wRref(F2)=0.1269, T= 296(2) K.
CCDC no.: 1910861
The asymmetric unit containing two crystallogaphically
independent molecules is shown in the figure. Table 1 con-
tains crystallographic data and Table 2 contains the list of
the atoms including atomic coordinates and displacement
parameters.
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Table 1: Data collection and handling.
Crystal: Yellow plate
Size: 0.55×0.38×0.12 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 0.20 mm−1
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: 29.7°,>99%
N(hkl)measured, N(hkl)unique, Rint: 17282, 7967, 0.039
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 5569
N(param)refined: 533
Programs: CrysAlisPRO [1], SHELX [2, 3],
WinGX/ORTEP [4]
Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
N1 0.81811(13) 0.74789(15) 0.8462(3) 0.0400(7)
N2 0.83674(13) 0.81117(15) 0.7963(3) 0.0398(7)
N3 0.06260(14) 0.75158(16) 0.8479(3) 0.0431(7)
N4 0.08813(14) 0.81248(15) 0.7989(3) 0.0428(7)
O1 1.04235(14) 0.63547(14) 0.3821(4) 0.0601(8)
O2 0.29649(15) 0.62024(15) 0.4201(3) 0.0622(8)
C1 0.99248(16) 0.73792(18) 0.4836(4) 0.0384(8)
C2 1.03887(17) 0.69742(19) 0.3894(4) 0.0427(8)
C3 1.07935(16) 0.74778(19) 0.3062(4) 0.0408(8)
C4 1.12964(19) 0.7355(2) 0.2039(4) 0.0485(10)
H4 1.143109 0.690972 0.181915 0.058*
C5 1.1592(2) 0.7909(2) 0.1356(4) 0.0533(11)
H5 1.192687 0.783807 0.065836 0.064*
C6 1.1393(2) 0.8566(2) 0.1704(5) 0.0521(10)
H6 1.159964 0.893400 0.123776 0.063*
C7 1.08948(19) 0.8691(2) 0.2729(4) 0.0494(9)
H7 1.076204 0.913712 0.294673 0.059*
C8 1.05960(17) 0.81350(19) 0.3428(4) 0.0411(8)
C9 1.00469(17) 0.81295(18) 0.4578(4) 0.0400(8)
H9A 1.020511 0.835516 0.544730 0.048*
H9B 0.963276 0.835431 0.424353 0.048*
C10 0.94833(17) 0.70713(19) 0.5740(4) 0.0409(8)
H10 0.948054 0.659466 0.571339 0.049*
C11 0.90116(17) 0.73834(19) 0.6748(4) 0.0375(8)
C12 0.85655(16) 0.70380(17) 0.7736(4) 0.0377(8)
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Table 2 (continued)
Atom x y z Uiso*/Ueq
C13 0.88595(17) 0.80659(19) 0.6949(4) 0.0410(8)
H13 0.906156 0.843210 0.646871 0.049*
C14 0.84909(17) 0.63101(18) 0.8031(4) 0.0408(8)
C15 0.89497(19) 0.57704(18) 0.7839(4) 0.0459(9)
H15 0.938232 0.581796 0.742941 0.055*
C16 0.8680(2) 0.5143(2) 0.8339(5) 0.0583(11)
H16 0.892066 0.473195 0.830501 0.070*
C17 0.8038(2) 0.5199(2) 0.8871(5) 0.0603(11)
H17 0.778610 0.483258 0.923364 0.072*
S1 0.77468(5) 0.60175(6) 0.87961(14) 0.0585(3)
C18 0.80614(17) 0.87052(18) 0.8567(4) 0.0430(8)
C19 0.7736(2) 0.8670(2) 0.9871(5) 0.0535(10)
H19 0.770456 0.825233 1.034912 0.064*
C20 0.7456(2) 0.9247(3) 1.0477(5) 0.0655(12)
H20 0.723937 0.921903 1.136678 0.079*
C21 0.7493(2) 0.9862(2) 0.9781(6) 0.0689(13)
H21 0.730526 1.025292 1.019562 0.083*
C22 0.7808(3) 0.9899(2) 0.8474(7) 0.0816(16)
H22 0.783078 1.031773 0.799857 0.098*
C23 0.8095(2) 0.9327(2) 0.7842(6) 0.0660(13)
H23 0.830642 0.935670 0.694720 0.079*
C24 0.24134(17) 0.7250(2) 0.5006(4) 0.0431(9)
C25 0.28958(18) 0.6827(2) 0.4147(4) 0.0470(9)
C26 0.32794(17) 0.7300(2) 0.3212(4) 0.0431(9)
C27 0.3787(2) 0.7156(2) 0.2204(4) 0.0513(10)
H27 0.392392 0.670710 0.202823 0.062*
C28 0.4082(2) 0.7695(2) 0.1471(4) 0.0562(11)
H28 0.442575 0.761079 0.079939 0.067*
C29 0.3870(2) 0.8361(2) 0.1732(5) 0.0567(11)
H29 0.407064 0.871915 0.122212 0.068*
C30 0.33686(19) 0.8505(2) 0.2727(5) 0.0534(10)
H30 0.323206 0.895474 0.289477 0.064*
C31 0.30698(17) 0.79674(19) 0.3478(4) 0.0432(8)
C32 0.25205(17) 0.79913(19) 0.4622(4) 0.0434(9)
H32A 0.267213 0.825256 0.545135 0.052*
H32B 0.210198 0.819351 0.424984 0.052*
C33 0.19715(18) 0.6974(2) 0.5946(4) 0.0450(9)
H33 0.198058 0.649930 0.602792 0.054*
C34 0.14812(18) 0.7329(2) 0.6848(4) 0.0430(9)
C35 0.09869(17) 0.70368(18) 0.7799(4) 0.0416(8)
C36 0.13895(18) 0.8023(2) 0.7014(4) 0.0453(9)
H36 0.163394 0.836433 0.653963 0.054*
C37a 0.0847(7) 0.6312(2) 0.8080(9) 0.0446(12)
C38a 0.0840(6) 0.5769(5) 0.7127(12) 0.059(3)
H38a 0.093464 0.580654 0.614892 0.071*
C39a 0.0670(4) 0.5145(3) 0.7834(7) 0.0597(14)
H39a 0.067362 0.472051 0.737618 0.072*
C40a 0.0503(4) 0.5228(3) 0.9233(7) 0.0645(16)
H40a 0.036576 0.487340 0.983676 0.077*
S2a 0.05747(9) 0.60634(9) 0.97576(18) 0.0614(6)
C37Ab 0.079(4) 0.6351(7) 0.827(5) 0.054(4)
C38Ab 0.043(2) 0.6150(12) 0.949(3) 0.058(4)
H38Ab 0.020552 0.644694 1.011504 0.069*
C39Ab 0.0464(19) 0.5426(11) 0.967(2) 0.058(4)
H39Ab 0.038416 0.520215 1.053783 0.070*
C40Ab 0.062(2) 0.5100(9) 0.843(3) 0.055(4)
Table 2 (continued)
Atom x y z Uiso*/Ueq
H40Ab 0.056163 0.463369 0.827059 0.066*
S2Ab 0.0954(9) 0.5655(8) 0.7204(16) 0.061(3)
C41 0.06147(18) 0.8750(2) 0.8532(4) 0.0454(9)
C42 0.0016(2) 0.8749(2) 0.9313(5) 0.0541(10)
H42 −0.022648 0.834272 0.944071 0.065*
C43 −0.0224(2) 0.9354(2) 0.9911(6) 0.0654(12)
H43 −0.062948 0.935425 1.043924 0.079*
C44 0.0130(3) 0.9946(2) 0.9728(6) 0.0702(13)
H44 −0.002466 1.034658 1.016449 0.084*
C45 0.0718(2) 0.9960(2) 0.8899(6) 0.0714(14)
H45 0.094976 1.037023 0.875170 0.086*
C46 0.0960(2) 0.9361(2) 0.8289(5) 0.0581(11)
H46 0.135249 0.936729 0.771918 0.070*
aOccupancy: 0.831(5), bOccupancy: 0.169(5).
Source of material
The title compound was synthesized based on a literature
procedure from reaction of equimolar amounts of 1-phenyl-3-
(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde and 2,3-dihydro-
1H-inden-1-one in boiling ethanol containing few drops of
piperidine as catalyst for 2 h [5]. Crystallization of the solid
obtained using dimethylformamide gave colorless crystals of
the title compound (87%).
Experimental details
All hydrogen atoms were placed in calculated positions and
refined using a riding model. Aromatic C—H distances were
set to 0.93 Å (AFIX 43 instruction in SHELXL [2, 3]) and their
U iso set to 1.2 times theUeq(C). Methylene C—Hdistances were
set to 0.97 Å and their U iso to 1.2 times the Ueq(C) (AFIX 23).
Crystal data, data collection and structure refinement details
are summarized in Table 1.
Comment
Pyrazoles exhibit a wide range of biological activities and
can be used as therapeutic agents such as celecoxib, rimon-
abant, difenamizole, betazole, and fezolamide [6–10]. There-
fore, synthesis of heterocycles containing pyrazole ring sys-
tems is always important [11–13].
The molecule of the title compound comprises indanone
(A), pyrazolyl (B), phenyl (C) and thiophenyl (D) ring systems.
The asymmetric unit consists of two independent molecules:
1 (C1—C23) and 2 (C24—C46). The thiophenyl group is disor-
dered in molecule 2 by a rotation of 180° about the Cthiophene–
Cpyrazole bond with component occupancies of 0.83(1) and
0.17(1). The twist angles between the planes through rings A–
B, B–C, B–D are 2.3(1)°, 19.1(2)°, 23.0(2)° for molecule 1 and
5.4(2)°, 13.8(2)°, 34.4(3)° for molecule 2. Bond lengths and
angles are in the typical ranges [14].
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In the structure, molecules 1 and 2 are arranged in pairs
with indanone centroid-centroid separation of 4.87 Å. The
pairs of molecules are stacked to form columns parallel to
[100]. Neighbouring columns are related by translation along
[001] and by 21 symmetry along [010]. C—H· · ·O interactions
form an extended network.
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